PAZOPANIB

Trials studying PAZOPANIB

• phase1Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteriaterminatedn=18
• phase2Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Canceractive not recruitingn=51
• phase2HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomasactive not recruitingn=47
• phase2Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trialactive not recruitingn=180
• phase2Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adultsactive not recruitingn=80
• phase3A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)active not recruitingn=333
• phase3Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)completedn=129
• phase2A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinomanot yet recruitingn=30